212 related articles for article (PubMed ID: 21796619)
61. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors.
Hoebeeck J; Michels E; Menten B; Van Roy N; Eggert A; Schramm A; De Preter K; Yigit N; De Smet E; De Paepe A; Laureys G; Vandesompele J; Speleman F
Int J Cancer; 2007 Feb; 120(3):533-8. PubMed ID: 17096344
[TBL] [Abstract][Full Text] [Related]
62. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification.
Valent A; Le Roux G; Barrois M; Terrier-Lacombe MJ; Valteau-Couanet D; Léon B; Spengler B; Lenoir G; Bénard J; Bernheim A
J Pathol; 2002 Dec; 198(4):495-501. PubMed ID: 12434419
[TBL] [Abstract][Full Text] [Related]
63. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Haug BH; Henriksen JR; Buechner J; Geerts D; Tømte E; Kogner P; Martinsson T; Flægstad T; Sveinbjørnsson B; Einvik C
Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
[TBL] [Abstract][Full Text] [Related]
64. Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases.
Cobrinik D; Ostrovnaya I; Hassimi M; Tickoo SK; Cheung IY; Cheung NK
Genes Chromosomes Cancer; 2013 Dec; 52(12):1150-66. PubMed ID: 24123354
[TBL] [Abstract][Full Text] [Related]
65. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization.
Beheshti B; Braude I; Marrano P; Thorner P; Zielenska M; Squire JA
Neoplasia; 2003; 5(1):53-62. PubMed ID: 12659670
[TBL] [Abstract][Full Text] [Related]
66. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma.
Santo EE; Ebus ME; Koster J; Schulte JH; Lakeman A; van Sluis P; Vermeulen J; Gisselsson D; Øra I; Lindner S; Buckley PG; Stallings RL; Vandesompele J; Eggert A; Caron HN; Versteeg R; Molenaar JJ
Oncogene; 2012 Mar; 31(12):1571-81. PubMed ID: 21860421
[TBL] [Abstract][Full Text] [Related]
67. 8q deletion in MYCN-amplified neuroblastoma of a child born from assisted reproductive technology.
Brassesco MS; Valera ET; de Oliveira FM; de Paula Queiroz RG; Scrideli CA; Sakamoto-Hojo ET; Tone LG
J Pediatr Hematol Oncol; 2009 Mar; 31(3):215-9. PubMed ID: 19262252
[TBL] [Abstract][Full Text] [Related]
68. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.
Tsai HY; Hsi BL; Hung IJ; Yang CP; Lin JN; Chen JC; Tsai SF; Huang SF
Hum Pathol; 2004 Nov; 35(11):1397-403. PubMed ID: 15668898
[TBL] [Abstract][Full Text] [Related]
69. Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.
Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; O'Meara A; Ryan E; Catchpoole D; Breatnach F
Cytogenet Genome Res; 2004; 106(1):49-54. PubMed ID: 15218241
[TBL] [Abstract][Full Text] [Related]
70. The MYCN oncogene is a direct target of miR-34a.
Wei JS; Song YK; Durinck S; Chen QR; Cheuk AT; Tsang P; Zhang Q; Thiele CJ; Slack A; Shohet J; Khan J
Oncogene; 2008 Sep; 27(39):5204-13. PubMed ID: 18504438
[TBL] [Abstract][Full Text] [Related]
71. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification.
De Brouwer S; De Preter K; Kumps C; Zabrocki P; Porcu M; Westerhout EM; Lakeman A; Vandesompele J; Hoebeeck J; Van Maerken T; De Paepe A; Laureys G; Schulte JH; Schramm A; Van Den Broecke C; Vermeulen J; Van Roy N; Beiske K; Renard M; Noguera R; Delattre O; Janoueix-Lerosey I; Kogner P; Martinsson T; Nakagawara A; Ohira M; Caron H; Eggert A; Cools J; Versteeg R; Speleman F
Clin Cancer Res; 2010 Sep; 16(17):4353-62. PubMed ID: 20719933
[TBL] [Abstract][Full Text] [Related]
72. Risk estimation in localized unresectable single copy MYCN neuroblastoma by the status of chromosomes 1p and 11q.
Simon T; Spitz R; Hero B; Berthold F; Faldum A
Cancer Lett; 2006 Jun; 237(2):215-22. PubMed ID: 16019135
[TBL] [Abstract][Full Text] [Related]
73. Association of MYCN amplification and 1p deletion in neuroblastomas with high tumor vascularity.
Ozer E; Altungoz O; Unlu M; Aygun N; Tumer S; Olgun N
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):181-6. PubMed ID: 17525631
[TBL] [Abstract][Full Text] [Related]
74. KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.
Munirajan AK; Ando K; Mukai A; Takahashi M; Suenaga Y; Ohira M; Koda T; Hirota T; Ozaki T; Nakagawara A
J Biol Chem; 2008 Sep; 283(36):24426-34. PubMed ID: 18614535
[TBL] [Abstract][Full Text] [Related]
75. Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.
Van Roy N; Jauch A; Van Gele M; Laureys G; Versteeg R; De Paepe A; Cremer T; Speleman F
Cancer Genet Cytogenet; 1997 Sep; 97(2):135-42. PubMed ID: 9283597
[TBL] [Abstract][Full Text] [Related]
76. Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma.
Ho N; Peng H; Mayoh C; Liu PY; Atmadibrata B; Marshall GM; Li J; Liu T
Cell Cycle; 2018; 17(6):749-758. PubMed ID: 29353549
[TBL] [Abstract][Full Text] [Related]
77. Correlation between the International Neuroblastoma Pathology Classification and genomic signature in neuroblastoma.
Nakazawa A; Haga C; Ohira M; Okita H; Kamijo T; Nakagawara A
Cancer Sci; 2015 Jun; 106(6):766-771. PubMed ID: 25827934
[TBL] [Abstract][Full Text] [Related]
78. Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.
Villamón E; Piqueras M; Mackintosh C; Alonso J; de Alava E; Navarro S; Noguera R
Virchows Arch; 2008 Jul; 453(1):47-55. PubMed ID: 18574593
[TBL] [Abstract][Full Text] [Related]
79. Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high-risk neuroblastoma.
Ooi WF; Re A; Sidarovich V; Canella V; Arseni N; Adami V; Guarguaglini G; Giubettini M; Scaruffi P; Stigliani S; Lavia P; Tonini GP; Quattrone A
Genes Chromosomes Cancer; 2012 Jun; 51(6):545-56. PubMed ID: 22337647
[TBL] [Abstract][Full Text] [Related]
80. Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.
Ma D; Chen Z; Patel KP; Mishra BM; Yao H; Abruzzo LV; Medeiros LJ; Wierda W; Keating M; Sargent R; Luthra R
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S17-24. PubMed ID: 22035742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]